News

The demand for higher throughput analytics is needed to support the paradigm shift that is emerging in the industry towards a deeper appreciation of the epitope diversity offered within an antibody library by applying higher resolution and higher throughput methods for epitope characterization at the earliest stages of research.

Carterra^® Inc., a provider of innovative drug discovery technologies, announced that its CEO, Josh Eckman, has been honored as a Rising Star by The University of Utah David Eccles School of Business during its 2018 Hall of Fame induction ceremony.

First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business

First Research Institution to Purchase Carterra’s High-Throughput Label-Free Biosensor to Support its Novel Antibody Discovery

First LSA instrument sales are to a broad range of initial customers, including large pharmaceutical, biotech, CRO and academic institutions.

Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization.

Learn about epitope binning for next-generation biotherapeutic discovery.

New corporate name and system reflect the evolution of the Company into a premier provider of biotherapeutic characterization tools.